SHAK STEVEN (Chief Scientific Officer) sold 37.4% of their position (50K shares) of GENOMIC HEALTH INC on the open market
Open‑market sale worth $3.59M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/7/2019ACC: 0001209191-19-044974
Officer· Chief Scientific Officer
Since Jul 2018
-50K
Net shares
Net seller
$3.59M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
50K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−22.53K
Price / share
$71.22
Trade value
$1.60M
% of position
16.8%
8/5/2019
133.79K→111.27K
Common Stock
Indirect
Shares
−2.47K
Price / share
$71.85
Trade value
$177.54K
% of position
2.2%
8/5/2019
111.27K→108.80K
Common Stock
Indirect
Shares
−16.86K
Price / share
$72.14
Trade value
$1.22M
% of position
15.5%
8/6/2019
108.80K→91.94K
Common Stock
Indirect
Shares
−8.14K
Price / share
$72.86
Trade value
$593.09K
% of position
8.9%
8/6/2019
91.94K→83.80K
Total
Net shares
−50K
Net value
-$3.59M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/5/2019 | S · Sale | −22.53K | $71.22 | $1.60M | 16.8% | 133.79K | 111.27K |
| Common Stock Indirect | 8/5/2019 | S · Sale | −2.47K | $71.85 | $177.54K | 2.2% | 111.27K | 108.80K |
| Common Stock Indirect | 8/6/2019 | S · Sale | −16.86K | $72.14 | $1.22M | 15.5% | 108.80K | 91.94K |
| Common Stock Indirect | 8/6/2019 | S · Sale | −8.14K | $72.86 | $593.09K | 8.9% | 91.94K | 83.80K |
| Total | −50K | -$3.59M | ||||||
Derivative Transactions0
No derivative transactions reported